Overview

Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether there is a benefit to giving a dopamine agonist to a patient with Parkinson's disease who is already being treated with levodopa.
Phase:
Phase 1
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
Boehringer Ingelheim
Treatments:
Dopamine
Dopamine Agents
Dopamine Agonists
Levodopa
Pramipexole